CHAPTER


DOI :10.26650/BB/CH22.2020.008.01   IUP :10.26650/BB/CH22.2020.008.01    Full Text (PDF)

COVID-19: Are There Lessons to be Learned from History?

Gönül Şengöz

The coronavirus infectious disease-19 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARSCoV-2), started in China and spread around the world. It was initially perceived as viral pneumonia. But as the process progressed, it was understood that it was progressing with a cytokine storm, macrophage activation syndrome, and multiple organ failure. The disease is fatal in the elderly and those with underlying disease. The frightening aspect of the disease is the lack of drugs and vaccines for specific treatment and prevention. It is not yet possible to predict how long, how intense and how severe the outbreak will be over time. This pandemic is neither the first nor the last health crisis to deeply affect the world. The pandemic will cause permanent changes in our lifestyle. Due to COVID-19, social, economic and cultural developments, and changes will accelerate or slow down. This pandemic will result in many new experiences, developments and innovations in the medical field. Lessons learned from the outbreak will form our roadmap until a new unknown. COVID-19 has emerged as a threat to the world. In the post pandemic period, changes will occur in the world. It is estimated that a long time will be needed to control this outbreak. In fact, we need mechanisms to anticipate biological threats that await humanity after this outbreak.


DOI :10.26650/BB/CH22.2020.008.01   IUP :10.26650/BB/CH22.2020.008.01    Full Text (PDF)

COVID-19: Tarihten Alınacak Dersler var mı?

Gönül Şengöz

Şiddetli akut solunum sendromu koronavirus-2’nin (SARS–CoV–2) etken olduğu Koronavirus hastalığı-2019 (COVID-19) küresel salgını Çin’de başlayıp tüm dünyaya yayılan, başlangıçta viral pnömoni gibi algılansa da ilerleyen süreçte sitokin fırtınası, makrofaj aktivasyon sendromu, çoklu organ yetmezliği ile seyrettiği anlaşılan bir hastalıktır. Hastalık daha çok yaşlılarda ve altta yatan hastalığı olanlarda mortal seyretmektedir. Bu hastalıkta henüz spesifik tedavi ve korunma için kullanabileceğimiz bir ilaç ya da aşının var olmayışı olayın korkutucu yanlarını ortaya koymaktadır. Salgının ne kadar uzun ne kadar yoğun ve ne kadar şiddetli olacağı hala öngörülememektedir. Tüm dünyayı derinden etkileyen bu salgın ilk sağlık krizi olmadığı gibi son da olmayacaktır. Diğer bütün salgınlar gibi geride izler bırakarak hayat tarzımızda değişikliklere neden olacaktır. Bu salgın nedeniyle sosyal, ekonomik ve kültürel alanlarda bazı gelişmeler ve değişmeler yaşanacaktır. Bununla birlikte salgın; tıp alanında birçok yeni deneyim, gelişme ve yeniliklerle sonuçlanarak ve çıkarılan dersler ile yeni bir bilinmeyene kadar yol haritamızı oluşturacaktır. COVID-19 tüm dünya için bir tehdit olarak ortaya çıkmıştır ve küresel salgın sonrası dönemde dünyada değişimler yaşanacaktır. Bu salgının kontrolü için daha alınacak uzun bir yol olduğu düşünülmektedir. Bundan sonra insanlığı bekleyen biyolojik tehditleri öngörecek mekanizmalara da ihtiyaç duyulacaktır.



References

  • 1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224): 565-74. google scholar
  • 2. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. 2020; 13(5): 667-73. google scholar
  • 3. Zhang T, Wu Q, Zhang Z. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 outbreak. Curr Biol. 2020; 30(7): 1346-51. google scholar
  • 4. Öztürk R, Taşova Y, Ayaz A. COVID-19: Pathogenesis, Genetic Polymorphism, Clinical Features and Laboratory Findings. Turk J Med Sci 2020;(50):638-57. google scholar
  • 5. Bulut C, Yasuyuki K. Epidemiology of COVID-19. Turk J Med Sci. 2020; (50): 563-70. google scholar
  • 6. Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. 2020; 30(8): 4381-9. google scholar
  • 7. Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, et al. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell. 2020; 181(4): 894-904. google scholar
  • 8. Soy M, Keser G, Atagündüz P, Tabak F. Cytokine storm in COVID-19: pathogenesis and overview of antiinflammatory agents used in treatment. Clin Rheumatol. 2020; 39(7): 2085-94. google scholar
  • 9. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. J Am Coll Cardiol. 2020; 75(23): 2950-73. google scholar
  • 10. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020; 39(6): 1011-19. google scholar
  • 11. Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020; 26: 729-34. google scholar
  • 12. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available from: https://coronavirus.jhu.edu/map.html. (25 Temmuz 2020) google scholar
  • 13. TC Sağlık Bakanlığı,COVID-19 Haftalık Durum Raporu, 06/07/2020 – 12/07/2020, Türkiye. Available from: https://dosyamerkez.saglik.gov.tr/Eklenti/37947,covid-19-haftalik-durum-raporu--6-12-temmuz-2020pdf. pdf?0&_tag1=3CC6DF03E969705DD67D168AD76EE59DA8DC875B google scholar
  • 14. Çelik İ, Saatçi E, Eyüboğlu FÖ. Emerging and reemerging respiratory viral infections up to Covid-19. Turk J Med Sci. 2020; (50): 557-62. google scholar
  • 15. Akın L, Gözel MG. Understanding dynamics of pandemics. Turk J Med Sci. 2020; (50): 515-9. google scholar
  • 16. Petersen E, Gökengin D. SARS-CoV-2 epidemiology and control, different scenarios for Turkey. Turk J Med Sci. 2020; 50(SI-1): 509-14. google scholar
  • 17. Turan C, Hacımustafaoğlu M. Enfeksiyon Hastalıklarında R0 Oranı ve Klinik Anlamı Nedir? J Pediatr Inf. 2020; 14(1): 55-6. google scholar
  • 18. Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, et al. The basic reprodiction number (R0) of measles: a systematic review. Lancet Infect Dis. 2017; 12: e420-28. Şengöz 9 google scholar
  • 19. Meehan MT, Rojas DP, Adekunle AI, Adegboye OA, Caldwell JM, Turek E, et al. Modelling insights into the COVID-19 pandemic. Paediatr Respir Rev. 2020; 35: 64-9. google scholar
  • 20. Şencan İ, Kuzi S. Global threat of COVID 19 and evacuation of the citizens of different countries. Turk J Med Sci. 2020; (50): 534-43. google scholar
  • 21. Fathizadeh H, Maroufi P, Momen-Heravi M, Dao S, Köse S, Ganbarov K, et al. Protection and disinfection policies against SARS-CoV-2 (COVID-19). Le Infezioni in Medicina. 2020; (2): 185-91. google scholar
  • 22. Çetin C, Kara A. Global surveillance, travel, and trade during a pandemic. Turk J Med Sci. 2020; (50): 527-33. google scholar
  • 23. Coronavirus disease (COVID-19) Situation Report – 186 Data as received by WHO from national authorities by 10:00 CEST, 24 July 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situationreports/20200724-covid-19-sitrep-186.pdf?sfvrsn=4da7b586_2 (25 Temmuz 2020) google scholar
  • 24. Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B et al. COVID-19: A promising cure for the global panic. Sci Total Environ. 2020; 725: 138277. doi: 10.1016/j.scitotenv.2020.138277 google scholar
  • 25. Zhoua MY, Xiea XL, Pengb YG, Wuc MJ, Denga XZ, Wud Y, et al. From SARS to COVID-19: What we have learned about children infected with COVID-19. Int J Infect Dis. 2020; 96: 710-4. google scholar
  • 26. Gensini GF , Yacoub MH, Conti AA. The concept of quarantine in history: from plague to SARS. J Infect. 2004; 49(4): 257-61. google scholar
  • 27. Tognotti E. Lessons from the History of Quarantine, from Plague to Influenza A. Emerg Infect Dis. 2013; 19(2): 254-9. google scholar
  • 28. Kılıç R, Ataman Hatipoğlu Ç, Güneş C. Quarantine and its legal dimension. Turk J Med Sci. 2020; (50): 544-8. google scholar
  • 29. Petersen E, Koopmans M, Go U, Hamer DH, Petrosillo N, Castelli F, et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. 2020; 20(9): e238-44. google scholar
  • 30. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020: 10.1002/jmv.25748. doi: 10.1002/jmv.25748 google scholar
  • 31. Ekins S, Mottin M, Ramos PRPS, Sousa BKP, Neves BJ, Foil DH, et al. Déjà vu: Stimulating open drug discovery for SARS-CoV-2. Drug Discov Today. 2020; 25(5): 928-41. google scholar
  • 32. Havers FP, Reed C, Lim T, Montgomery JM, Klena JD, Hall AJ, et al. Seroprevalence of Antibodies to SARSCoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA Intern Med. 2020. doi: 10.1001/ jamainternmed.2020.4130 google scholar
  • 33. Joyner MJ, Bruno KA, Klassen SA, Kunze KL, Johnson PW, Lesser ER, et al. Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients. Mayo Clin Proc. 2020; 95(9): 1888-97. google scholar
  • 34. CDC COVID Data Tracker. Available from: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/casesin-us.html. (25 Temmuz 2020) google scholar
  • 35. Beyazadam D, Alimoglu O.Healthcare Workers Are Losing Their Lives in the Battle of Covid-19 All Over the Globe. Anadolu Kliniği Tıp Bilimleri Dergisi. 2020; 25(1): 183-4. google scholar
  • 36. Xiao J, Fang M, Chen Q, He B. SARS, MERS and COVID-19 among healthcare workers: A narrative review. J Infect Public Health. 2020; 13(6): 843-8. google scholar


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.